pyrazines has been researched along with 1,1-diphenyl-2-picrylhydrazyl in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakano, Y; Ozawa, T | 1 |
Deng, HW; Deng, PY; Hu, CP; Li, YJ; Zhou, Y | 1 |
Cheng, YN; Guo, XL; Liu, XY; Ou, Y; Zhai, L | 1 |
Han, Z; Hao, X; Ma, B; Zhu, C | 1 |
Han, Z; Hao, X; Ma, H; Qi, G; Zhu, C | 1 |
5 other study(ies) available for pyrazines and 1,1-diphenyl-2-picrylhydrazyl
Article | Year |
---|---|
The radical scavenging abilities of a new anti-nephritic drug, OPC-15161.
Topics: Bepridil; Biphenyl Compounds; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Hydroxyl Radical; Picrates; Pyrazines; Superoxides | 1996 |
The protective effects of ligustrazine on ischemia-reperfusion and DPPH free radical-induced myocardial injury in isolated rat hearts.
Topics: Animals; Biphenyl Compounds; Cardiotonic Agents; Ligusticum; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phytotherapy; Picrates; Plant Extracts; Pyrazines; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2004 |
TMPDP, a tetramethylpyrazine derivative, protects vascular endothelial cells from oxidation damage by hydrogen peroxide.
Topics: Antioxidants; Biphenyl Compounds; Calcium; Cell Survival; Endothelium, Vascular; Free Radical Scavengers; Humans; Hydrogen Peroxide; L-Lactate Dehydrogenase; Lipid Peroxidation; Malondialdehyde; Myocytes, Smooth Muscle; Oxidants; Picrates; Pyrazines; Reactive Oxygen Species; Superoxide Dismutase | 2010 |
A series of pyrido[2,3-b]pyrazin-3(4H)-one derivatives as aldose reductase inhibitors with antioxidant activity.
Topics: Aldehyde Reductase; Antioxidants; Biphenyl Compounds; Catalytic Domain; Drug Design; Enzyme Inhibitors; Molecular Docking Simulation; Picrates; Pyrazines | 2016 |
Novel 2-phenoxypyrido[3,2-
Topics: Aldehyde Reductase; Antioxidants; Biphenyl Compounds; Drug Design; Enzyme Inhibitors; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Structure; Picrates; Pyrazines; Structure-Activity Relationship | 2019 |